Kurt A Schalper Selected Research

Kurt A Schalper Research Topics

Disease

63	Neoplasms (Cancer) 04/2024 - 08/2013
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 06/2013
10	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2014
9	Melanoma (Melanoma, Malignant) 04/2024 - 06/2012
5	Neoplasm Metastasis (Metastasis) 04/2024 - 08/2013
5	Lung Neoplasms (Lung Cancer) 10/2023 - 01/2017
4	Carcinoma (Carcinomatosis) 11/2021 - 09/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 10/2016
2	Triple Negative Breast Neoplasms 01/2021 - 12/2018
2	Brain Neoplasms (Brain Tumor) 01/2020 - 01/2020
2	Adenocarcinoma of Lung 01/2017 - 11/2016
2	Ischemia 02/2009 - 08/2007
1	Persistent Infection 10/2023
1	Adenocarcinoma 01/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Carcinogenesis 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2021
1	Bites and Stings (Sting) 01/2021
1	Central Nervous System Diseases (CNS Diseases) 01/2020
1	Obesity 01/2019
1	Disease Progression 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Inflammation (Inflammations) 01/2019

Drug/Important Bio-Agent (IBA)

19	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2015
18	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2018
15	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2009
10	B7-H1 AntigenIBA 01/2022 - 01/2014
6	Messenger RNA (mRNA)IBA 11/2021 - 01/2014
5	AntibodiesIBA 01/2022 - 08/2013
4	Interleukin-8 (Interleukin 8)IBA 10/2021 - 11/2017
3	ChemokinesIBA 04/2024 - 11/2017
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 01/2021
3	Monoclonal AntibodiesIBA 01/2022 - 06/2013
3	Keratins (Keratin)IBA 01/2022 - 03/2015
3	AntigensIBA 12/2021 - 08/2013
3	NivolumabIBA 01/2020 - 09/2015
3	LigandsIBA 08/2019 - 01/2014
2	veliparibIBA 01/2023 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2022
2	DAPIIBA 01/2022 - 03/2015
2	ChromatinIBA 11/2021 - 01/2021
2	InterferonsIBA 11/2021 - 01/2021
2	Formaldehyde (Formol)FDA Link 10/2021 - 12/2018
2	ParaffinIBA 12/2018 - 06/2012
2	Estrogen ReceptorsIBA 12/2018 - 01/2016
2	Hormones (Hormone)IBA 10/2017 - 05/2014
2	ConnexinsIBA 10/2009 - 08/2007
2	Connexin 43 (Connexin43)IBA 02/2009 - 08/2007
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2023
1	Hematoxylin (Haematoxylon)IBA 10/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	olaparibIBA 01/2023
1	atezolizumabIBA 01/2023
1	O-(6)-methylguanineIBA 01/2023
1	Carcinoembryonic AntigenIBA 01/2023
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2023
1	Temozolomide (Temodar)FDA LinkGeneric 01/2023
1	MethyltransferasesIBA 01/2023
1	SYTO 13IBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	dostarlimabIBA 01/2022
1	Syk KinaseIBA 01/2022
1	Guanosine Triphosphate (GTP)IBA 01/2022
1	HLA-DR Antigens (HLA-DR)IBA 01/2022
1	OligonucleotidesIBA 01/2022
1	CytokinesIBA 01/2022
1	ras-GRF1 (ras GRF1)IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Mucin-3IBA 01/2022
1	OX40 LigandIBA 11/2021
1	Lipid NanoparticlesIBA 11/2021
1	Transcription Factors (Transcription Factor)IBA 11/2021
1	Histone-Lysine N-MethyltransferaseIBA 11/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2021
1	Peroxidase (Myeloperoxidase)IBA 10/2021
1	Histones (Histone)IBA 10/2021
1	Granzymes (Granzyme)IBA 10/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	HLA-A Antigens (HLA-A)IBA 01/2021
1	HLA-B Antigens (HLA-B)IBA 01/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021
1	pembrolizumabIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	IpilimumabIBA 01/2020
1	Everolimus FDA Link 01/2020
1	Chimeric Antigen ReceptorsIBA 11/2019
1	Cancer VaccinesIBA 11/2019
1	Bispecific AntibodiesIBA 11/2019
1	LeptinIBA 01/2019
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2018
1	CD163 antigenIBA 12/2018
1	Matrix Metalloproteinases (MMPs)IBA 12/2018

Therapy/Procedure

30	Immunotherapy 04/2024 - 01/2016
19	Therapeutics 04/2024 - 05/2014
4	Radiotherapy 01/2023 - 10/2016
2	Neoadjuvant Therapy 10/2023 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2019
1	Duration of Therapy 01/2020